Comparable efficacy of bimekizumab for hidradenitis suppurativa with two- and four-week dosing intervals: a systematic review and meta-analysis

Arch Dermatol Res. 2024 Dec 5;317(1):72. doi: 10.1007/s00403-024-03569-x.

Authors

Sandesh Raja¹, Asfia Qammar², Muhammad Hamza Shuja³, Adarsh Raja⁴

Affiliations

¹ Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. [email protected].
² Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas, TX, USA.
³ Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
⁴ Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan.

PMID: 39636396
DOI: 10.1007/s00403-024-03569-x

No abstract available

Publication types

Letter